BioCentury | Oct 21, 2013
Finance

Immunotherapy top up

...BioTech; Wellington Partners; MIG Funds; AT Impf; Grazia Equity; EMBL Ventures; SB Asset Management; KfW; National Technology Enterprises...
BioCentury | Nov 15, 2010
Financial News

mtm financial update

...round to €46 million ($63.3 million). HBM BioVentures; Wellington Partners; and Gilde co-lead the financing. National Technology Enterprises...
BioCentury | Sep 27, 2010
Financial News

NewBridge Pharmaceuticals completes venture financing

...UAE Business: Endocrine, Cardiovascular, Metabolic Date completed: 9/20/10 Type: Venture financing Raised: $12 million Investors: National Technology Enterprises...
BioCentury | Sep 27, 2010
Finance

Phase III top off

...Impf. Existing investors Wellington Partners; Grazia Equity; EMBL Ventures; Renaissance PME; Mona Lisa Capital; KfW; National Technology Enterprises...
BioCentury | Sep 27, 2010
Financial News

immatics completes venture financing

...Impf GmbH; Wellington Partners; Grazia Equity; EMBL Ventures; Renaissance PME; Mona Lisa Capital AG; KfW; National Technology Enterprises...
BioCentury | Sep 21, 2010
Financial News

dievini Hopp co-leads EUR 53.8M immatics round

...BioTech. Existing investors Wellington Partners; Grazia Equity; EMBL Ventures; Renaissance PME; Mona Lisa Capital; KfW; National Technology Enterprises...
BioCentury | May 3, 2010
Financial News

Oxford Immunotec financial update

...Kaiser Permanente Ventures, also a new investor, joined existing investors Spark Ventures; Clarus; Wellington Partners; National Technology Enterprises...
BioCentury | Nov 5, 2007
Finance

Ebb & Flow

...FDA review. New investors Clarus Ventures and Wellington Partners led the offering. Another new investor, National Technology Enterprises...
BioCentury | Oct 30, 2007
Top Story

Oxford Immunotec raises $40 million

...$40 million in a private round led by new investors Clarus Ventures and Wellington Partners. National Technology Enterprises...
BioCentury | May 7, 2007
Finance

Global visibility

...domestic market. In the recent E40 million round for immatics, we were able to attract National Technology Enterprises...
Items per page:
1 - 10 of 11
BioCentury | Oct 21, 2013
Finance

Immunotherapy top up

...BioTech; Wellington Partners; MIG Funds; AT Impf; Grazia Equity; EMBL Ventures; SB Asset Management; KfW; National Technology Enterprises...
BioCentury | Nov 15, 2010
Financial News

mtm financial update

...round to €46 million ($63.3 million). HBM BioVentures; Wellington Partners; and Gilde co-lead the financing. National Technology Enterprises...
BioCentury | Sep 27, 2010
Financial News

NewBridge Pharmaceuticals completes venture financing

...UAE Business: Endocrine, Cardiovascular, Metabolic Date completed: 9/20/10 Type: Venture financing Raised: $12 million Investors: National Technology Enterprises...
BioCentury | Sep 27, 2010
Finance

Phase III top off

...Impf. Existing investors Wellington Partners; Grazia Equity; EMBL Ventures; Renaissance PME; Mona Lisa Capital; KfW; National Technology Enterprises...
BioCentury | Sep 27, 2010
Financial News

immatics completes venture financing

...Impf GmbH; Wellington Partners; Grazia Equity; EMBL Ventures; Renaissance PME; Mona Lisa Capital AG; KfW; National Technology Enterprises...
BioCentury | Sep 21, 2010
Financial News

dievini Hopp co-leads EUR 53.8M immatics round

...BioTech. Existing investors Wellington Partners; Grazia Equity; EMBL Ventures; Renaissance PME; Mona Lisa Capital; KfW; National Technology Enterprises...
BioCentury | May 3, 2010
Financial News

Oxford Immunotec financial update

...Kaiser Permanente Ventures, also a new investor, joined existing investors Spark Ventures; Clarus; Wellington Partners; National Technology Enterprises...
BioCentury | Nov 5, 2007
Finance

Ebb & Flow

...FDA review. New investors Clarus Ventures and Wellington Partners led the offering. Another new investor, National Technology Enterprises...
BioCentury | Oct 30, 2007
Top Story

Oxford Immunotec raises $40 million

...$40 million in a private round led by new investors Clarus Ventures and Wellington Partners. National Technology Enterprises...
BioCentury | May 7, 2007
Finance

Global visibility

...domestic market. In the recent E40 million round for immatics, we were able to attract National Technology Enterprises...
Items per page:
1 - 10 of 11